More
    Guided Solutions - Connecting Talent With Innovation/div>

    Prodeon gets FDA clearance for BPH-treating nitinol implant

    Prodeon Medical announced that it received FDA 510(k) clearance for its Urocross expander system. Sunnyvale, California-based Prodeon designed Urocross as a novel, non-permanent implant technology for treating lower urinary tract symptoms (LUTS) associated with benign...

    Prodeon gets FDA clearance for BPH-treating nitinol implant

    Prodeon Medical announced that it received FDA 510(k) clearance for its Urocross expander system. Sunnyvale, California-based Prodeon designed Urocross as a novel, non-permanent implant technology...

    CMR Surgical and Nvidia collab to train next-gen surgical robots

    CMR Surgical announced a new effort with Nvidia to train the next generation of intelligent surgical systems. The Cambridge, U.K.–based based surgical robot developer unveiled...

    Monteris Medical raises $28M Series E for robotic neurosurgery tech

    Monteris Medical has closed a $28 million Series E equity financing round as it continues to advance its robotic minimally invasive neurosurgery technology. Minnetonka, Minnesota–based...

    Senseonics reports sustained year-long CGM implant outcomes

    Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Senseonics reports sustained year-long CGM implant outcomes

    Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive...

    Arsenal Medical announces first patient treated with ResQFoam

    Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...

    TECLens begins first-in-human trial for qCXL vision correction technology

    TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...

    VESTECK announces the results for SUTURE-TIGHT Endovascular Repair Catheter

    VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...

    Innovation

    Regulatory Approvals

    Prodeon gets FDA clearance for BPH-treating nitinol implant

    Prodeon Medical announced that it received FDA 510(k) clearance for its Urocross expander system. Sunnyvale, California-based Prodeon designed Urocross as a novel, non-permanent implant technology...

    CMR Surgical and Nvidia collab to train next-gen surgical robots

    CMR Surgical announced a new effort with Nvidia to train the next generation of intelligent surgical systems. The Cambridge, U.K.–based based surgical robot developer unveiled...

    Monteris Medical raises $28M Series E for robotic neurosurgery tech

    Monteris Medical has closed a $28 million Series E equity financing round as it continues to advance its robotic minimally invasive neurosurgery technology. Minnetonka, Minnesota–based...

    Senseonics reports sustained year-long CGM implant outcomes

    Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive...

    M&A

    Archives

    Latest articles